1.
Endoscopy
; 56(S 01): E299-E300, 2024 Dec.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38569500
2.
Intern Med
; 61(8): 1145-1150, 2022 Apr 15.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34565776
RESUMEN
Fontan-associated liver disease (FALD) caused by long-term systemic venous congestion following the Fontan procedure may eventually lead to hepatocellular carcinoma (HCC). Treatment strategies for HCC due to FALD (FALD-HCC) remain unclear. We herein report a 35-year-old man with FALD-HCC that was well controlled by 3 cycles of continuous infusion of 5-fluorouracil and low-dose cisplatin (low-dose FP therapy) combined with 60 Gy of radiation therapy. However, the patient ultimately died of extrahepatic metastases. A pathological autopsy revealed more than 90% necrosis in the primary HCC lesion. This case suggests that low-dose FP therapy might be effective in FALD-HCC.
Asunto(s)
Carcinoma Hepatocelular , Procedimiento de Fontan , Neoplasias Hepáticas , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma Hepatocelular/etiología , Carcinoma Hepatocelular/terapia , Cisplatino/uso terapéutico , Fluorouracilo/uso terapéutico , Procedimiento de Fontan/efectos adversos , Humanos , Infusiones Intraarteriales/efectos adversos , Neoplasias Hepáticas/patología , Masculino , Complicaciones Posoperatorias/etiología
3.
Pediatr Int
; 45(6): 743-6, 2003 Dec.
Artículo
en Inglés
| MEDLINE
| ID: mdl-14651555